GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 44 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 250,200 | $1,394,000 | 1.15% |
| P.A.W. CAPITAL CORP | 100,000 | $557,000 | 0.67% |
| 683 Capital Management, LLC | 649,295 | $3,617,000 | 0.32% |
| MEITAV INVESTMENT HOUSE LTD | 476,190 | $2,652,000 | 0.14% |
| Park West Asset Management LLC | 363,700 | $2,026,000 | 0.09% |
| Nantahala Capital Management | 308,628 | $1,719,000 | 0.08% |
| Laird Norton Wetherby Wealth Management, LLC | 10,000 | $56,000 | 0.01% |
| J. Goldman & Co LP | 26,000 | $145,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 15,068 | $76,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,244 | $107,000 | 0.00% |